About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Maryland | 690 Studies

Clinical Trials Prostate CancerMaryland

Prostate Cancer Clinical Trials in Maryland

Find 690 clinical trials for prostate cancer near Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 141-160 of 690 trials

Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 163 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyThe purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects…NCT02960022·Anchorage, Alaska and 232 others

CompletedStudy of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate CancerThis study is being done to determine the safety, biodistribution, and radiation dosimetry of 18F-DCFPyL, and to detect prostate cancer by visual analysis.NCT02151760·Baltimore, Maryland

Approved for marketingStudy of Abiraterone Acetate in Patients With Advanced Prostate CancerThe purpose of this study is to collect additional safety information on abiraterone acetate administered with prednisone to patients with metastatic castration-resistant prostate…NCT01217697·Birmingham, Alabama and 296 others

CompletedA Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate CancerThis is a Phase I Dose-Escalation Study of BMS641988 in Patients with Castration-Resistant Prostate Cancer.NCT00326586·Baltimore, Maryland and 2 others

CompletedAndrogen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00006359·Lewes, Delaware and 25 others

CompletedExploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate CancerExploratory study in adult males with metastatic prostate cancer intended to characterize the pharmacokinetics and biodistribution of PSMA-Targeted \[In-111\]-Labeled Trillium…NCT05773703·Miami, Florida and 3 others

CompletedProstate Cancer Localization With a Multiparametric Magnetic Resonance (MR) ApproachThe primary objective of this prospective multi-centre study is to prove the diagnostic accuracy of in vivo 3T multi-modality Magnetic Resonance Imaging (high resolution…NCT01138527·Los Angeles, California and 8 others

CompletedHypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the ProstateThis will be a Phase II study evaluating the effectiveness and toxicity of a specific radiation therapy regimen.NCT00809991·Baltimore, Maryland

UnknownClariCore™ Biopsy System in Patients Undergoing Radical Retropubic ProstatectomyThe purpose of the study is to collect information on prostate tissue biopsies collected with the ClariCore System during a radical prostatectomy procedure.NCT02773940·Baltimore, Maryland and 1 other

CompletedSafety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)Background: \- This cancer vaccine was developed to help teach the body's immune system to attack and destroy cancer cells.NCT02179515·Bethesda, Maryland

RecruitingImage-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CTThe Principal Investigator's (PI) working hypothesis is that the PI can utilize the high predictive value of 18F-DCFPyl PSMA to identify clinically significant tumors in patients…NCT03861676·Baltimore, Maryland

Active not recruitingSafety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate CancerThe purpose of this first-in-man study is to evaluate safety and tolerability of ODM-208 in patients with metastatic castration-resistant prostate cancer.NCT03436485·Baltimore, Maryland and 19 others

CompletedBehavioral Weight Loss Program for Cancer Survivors in MarylandBehavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration ProjectNCT04534309·Baltimore, Maryland

WithdrawnA Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate CancerThis is a Phase I/Ib study of Radium-223 in combination with Tasquinimod for patients with bone metastases from castration-resistant prostate cancer (CRPC).NCT02396368·Baltimore, Maryland

Recruiting18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation TherapyBackground: Identifying medium- and high-risk prostate cancer early may allow for treatments to work. But identification can be hard.NCT05155046·Bethesda, Maryland

Active not recruitingPhase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerThe purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized…NCT01436968·Gilbert, Arizona and 72 others

TerminatedStudy of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerBone metastases and associated pain are a major cause of morbidity and mortality in castration-resistant prostate cancer (CRPC).NCT01522443·Scottsdale, Arizona and 81 others

CompletedA Selective Androgen Receptor Modulator for Symptom Management in Prostate CancerThis research study is studying the use of a targeted therapy called LY SARM, which is an investigational drug from a new class of molecules called Selective Androgen Receptor…NCT02499497·Gainesville, Florida and 3 others

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 581 others

PreviousPage 8 of 35Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma